Inventor
GUNDO DIEDRICH
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07KPeptides28%
G11CStatic stores8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
PatentTitleYear
12,435,155CD137 binding molecules and uses thereof202511,942,149Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof202411,795,226Bispecific CD16-binding molecules and their use in the treatment of disease202311,525,012Binding molecules specific for CD73 and uses thereof202211,459,394Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof202211,401,344Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients202211,242,402ADAM9-binding molecules, and methods of use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to MACROGENICS INC (5)· patent assignee history
2022Patents assigned to LABORATORY CORP AMERICA HOLDINGS (1)· patent assignee history
2022Patents assigned to MEDIMMUNE LTD (1)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MACROGENICS INC | 5 | 2022–2025 |
| LABORATORY CORP AMERICA HOLDINGS | 1 | 2022 |
| MEDIMMUNE LTD | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2025 |